Sensus Healthcare Analyst Ratings
Sensus Healthcare Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 312.37% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 08/07/2023 | 312.37% | HC Wainwright & Co. | $10 → $8 | Maintains | Buy |
| 05/04/2023 | 415.46% | HC Wainwright & Co. | $16 → $10 | Reiterates | → Buy |
| 05/04/2023 | 260.82% | Alliance Global Partners | $14.5 → $7 | Maintains | Buy |
| 02/10/2023 | 724.74% | HC Wainwright & Co. | → $16 | Reiterates | → Buy |
| 02/10/2023 | 647.42% | Alliance Global Partners | $16.5 → $14.5 | Maintains | Buy |
| 11/04/2022 | 750.52% | Alliance Global Partners | $17.5 → $16.5 | Maintains | Buy |
| 05/06/2022 | 724.74% | HC Wainwright & Co. | $13 → $16 | Maintains | Buy |
| 03/03/2022 | 570.1% | HC Wainwright & Co. | $12 → $13 | Maintains | Buy |
| 02/14/2022 | 518.56% | HC Wainwright & Co. | $10 → $12 | Maintains | Buy |
| 12/02/2021 | 415.46% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 11/05/2021 | 363.92% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 08/06/2021 | 260.82% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 03/01/2021 | 209.28% | HC Wainwright & Co. | $4 → $6 | Maintains | Buy |
| 02/26/2021 | 209.28% | Roth Capital | $4 → $6 | Maintains | Buy |
| 11/09/2020 | 106.19% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 05/11/2020 | 54.64% | B. Riley Securities | $5.5 → $3 | Maintains | Neutral |
| 05/08/2020 | 157.73% | HC Wainwright & Co. | $8 → $5 | Reiterates | → Buy |
| 11/07/2019 | 183.51% | B. Riley Securities | $14 → $5.5 | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/13/2023 | 312.37% | HC Wainwright & Co. | → 8 美元 | 重申 | 购买 → 购买 |
| 08/07/2023 | 312.37% | HC Wainwright & Co. | 10 美元 → 8 美元 | 维护 | 买 |
| 05/04/2023 | 415.46% | HC Wainwright & Co. | 16 美元 → 10 美元 | 重申 | → 购买 |
| 05/04/2023 | 260.82% | 联盟全球合作伙伴 | 14.5 美元 → 7 美元 | 维护 | 买 |
| 02/10/2023 | 724.74% | HC Wainwright & Co. | → 16 美元 | 重申 | → 购买 |
| 02/10/2023 | 647.42% | 联盟全球合作伙伴 | 16.5 美元 → 14.5 美元 | 维护 | 买 |
| 2022 年 4 月 11 日 | 750.52% | 联盟全球合作伙伴 | 17.5 美元 → 16.5 美元 | 维护 | 买 |
| 2022 年 6 月 5 日 | 724.74% | HC Wainwright & Co. | 13 美元 → 16 美元 | 维护 | 买 |
| 2022 年 3 月 3 日 | 570.1% | HC Wainwright & Co. | 12 美元 → 13 美元 | 维护 | 买 |
| 02/14/2022 | 518.56% | HC Wainwright & Co. | 10 美元 → 12 美元 | 维护 | 买 |
| 2021 年 2 月 12 日 | 415.46% | HC Wainwright & Co. | 9 美元 → 10 美元 | 维护 | 买 |
| 2021 年 5 月 11 日 | 363.92% | HC Wainwright & Co. | 7 美元 → 9 美元 | 维护 | 买 |
| 08/06/2021 | 260.82% | HC Wainwright & Co. | 6 美元 → 7 美元 | 维护 | 买 |
| 2021 年 1 月 3 日 | 209.28% | HC Wainwright & Co. | 4 美元 → 6 美元 | 维护 | 买 |
| 2021 年 2 月 26 日 | 209.28% | 罗斯资本 | 4 美元 → 6 美元 | 维护 | 买 |
| 11/09/2020 | 106.19% | HC Wainwright & Co. | 5 美元 → 4 美元 | 维护 | 买 |
| 05/11/2020 | 54.64% | B. 莱利证券 | 5.5 美元 → 3 美元 | 维护 | 中立 |
| 05/08/2020 | 157.73% | HC Wainwright & Co. | 8 美元 → 5 美元 | 重申 | → 购买 |
| 11/07/2019 | 183.51% | B. 莱利证券 | 14 美元 → 5.5 美元 | 降级 | 买入 → 中性 |
What is the target price for Sensus Healthcare (SRTS)?
Sensus Healthcare (SRTS) 的目标价格是多少？
The latest price target for Sensus Healthcare (NASDAQ: SRTS) was reported by HC Wainwright & Co. on November 13, 2023. The analyst firm set a price target for $8.00 expecting SRTS to rise to within 12 months (a possible 312.37% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年11月13日公布了Sensus Healthcare（纳斯达克股票代码：SRTS）的最新目标股价。该分析公司将目标股价定为8.00美元，预计SRTS将在12个月内升至12个月内（可能上涨312.37％）。去年有6家分析公司公布了评级。
What is the most recent analyst rating for Sensus Healthcare (SRTS)?
分析师对Sensus Healthcare（SRTS）的最新评级是多少？
The latest analyst rating for Sensus Healthcare (NASDAQ: SRTS) was provided by HC Wainwright & Co., and Sensus Healthcare reiterated their buy rating.
HC Wainwright & Co. 提供了Sensus Healthcare（纳斯达克股票代码：SRTS）的最新分析师评级，Sensus Healthcare重申了其买入评级。
When is the next analyst rating going to be posted or updated for Sensus Healthcare (SRTS)?
Sensus Healthcare（SRTS）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensus Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensus Healthcare was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Sensus Healthcare的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Sensus Healthcare的最新评级是在2023年11月13日发布的，因此您应该预计下一个评级将在2024年11月13日左右公布。
Is the Analyst Rating Sensus Healthcare (SRTS) correct?
分析师对 Sensus Healthcare (SRTS) 的评级正确吗
While ratings are subjective and will change, the latest Sensus Healthcare (SRTS) rating was a reiterated with a price target of $0.00 to $8.00. The current price Sensus Healthcare (SRTS) is trading at is $1.94, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的Sensus Healthcare（SRTS）评级，目标股价为0.00美元至8.00美元。Sensus Healthcare（SRTS）目前的交易价格为1.94美元，在分析师的预测区间内。